DIN 00613215 — TEVA-SPIRONOLACTONE 25 MG
TEVA-SPIRONOLACTONE is a tablet of Spironolactone marketed by TEVA CANADA LIMITED. The full Spironolactone monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 00613215
- Brand name
- TEVA-SPIRONOLACTONE
- Active ingredient
- Spironolactone
- Strength
- 25 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- TEVA CANADA LIMITED
- Health Canada status
- MARKETED
- Drug class
- Aldosterone antagonist (potassium-sparing diuretic)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Spironolactone products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02518848 | JAMP SPIRONOLACTONE | 100 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED |
| 02518821 | JAMP SPIRONOLACTONE | 25 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED |
| 02488159 | MINT-SPIRONOLACTONE | 100 MG | TABLET | MINT PHARMACEUTICALS INC | MARKETED |
| 02488140 | MINT-SPIRONOLACTONE | 25 MG | TABLET | MINT PHARMACEUTICALS INC | MARKETED |
| 00613223 | TEVA-SPIRONOLACTONE | 100 MG | TABLET | TEVA CANADA LIMITED | MARKETED |